GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3301 - 3325 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 2 15 mild
G51175PR
533
IgA Patient 2 15 mild
G77974XY
533
IgA Patient 4 12 mild
G32699RJ
533
IgA Patient 2 24 mild
G71469XA
534
IgA Patient 4 12 mild
G12200GB
534
IgA Patient 2 3 mild
G21290RB
535
IgA Patient 2 3 mild
G71469XA
537
IgA Patient 3 4 mild
G43534QA
537
IgG Patient 4 12 mild
G48898TH
537
IgA Patient 2 3 mild
G76355TG
538
IgM Patient 3 11 mild
G21675ZL
539
IgM Patient 2 3 mild
G93351GM
541
IgA Patient 3 11 mild
G81315DD
541
IgM Patient 1 22 moderate
G00057MO
543
IgA Patient 2 24 mild
G72424VO
543
IgA Patient 3 4 mild
G78255UI
543
IgA Patient 2 24 mild
G86156UJ
544
IgA Patient 2 24 mild
G61399NC
546
IgM Patient 2 3 mild
G09609EN
547
IgG Patient 3 4 mild
G15209MJ
547
IgG Patient 4 12 mild
G61399NC
547
IgA Patient 2 3 mild
G61751GZ
548
IgM Patient 3 4 mild
G00066MO
551
IgM Patient 4 12 mild
G21675ZL
551
IgG Patient 4 12 mild
G30839DN
552

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024